Flagship Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.2K Buy
70
+39
+126% +$12.8K 0.01% 237
2025
Q4
$10.9K Sell
31
-25
-45% -$8.45K ﹤0.01% 320
2025
Q3
$18.1K Sell
56
-14
-20% -$4.35K 0.01% 295
2025
Q2
$27.2K Hold
70
0.01% 251
2025
Q1
$30.4K Hold
70
0.01% 233
2024
Q4
$25.8K Buy
+70
New +$29.3K 0.02% 236

Other funds holding ELV

Flagship Wealth Advisors's ELV Position: Q1 2026 in Review

Flagship Wealth Advisors increased its Elevance Health (ELV) stake by 126% in Q1 2026, buying an estimated $12.8K and bringing the position to 70 shares worth $27.2K. The position accounts for 0.01% of the portfolio, ranked #237.

Flagship Wealth Advisors first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $30.4K in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Flagship Wealth Advisors held 70 shares of Elevance Health worth $27.2K as of Q1 2026.
  • Flagship Wealth Advisors bought 39 Elevance Health shares in Q1 2026, an estimated $12.8K.
  • Elevance Health made up 0.01% of Flagship Wealth Advisors's portfolio in Q1 2026, its #237 holding.
  • Flagship Wealth Advisors first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
  • Flagship Wealth Advisors's Elevance Health position peaked at $30.4K in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Flagship Wealth Advisors's 13F filing for Q1 2026, filed 1 Jun 2026.